Abbott Defeated In HCV Patent Spat
In a blow to Abbott Laboratories, a federal judge has upheld a jury's decision to award Belgian biotechnology company Innogenetics NV $7 million in damages in the duo's long-standing battle over...To view the full article, register now.
Already a subscriber? Click here to view full article